PHAGEinLYON Clinic Cohort Study: a Descriptive Study of Severe Infections Treated With Phage Therapy at the HCL.
Non Interventional Retrospective and Prospective Single Center Descriptive Study of Severe Infections Treated With Phage Therapy at the Hospices Civils de Lyon (PHAGEinLYON Clinic Cohort Study).
Hospices Civils de Lyon
250 participants
Feb 1, 2023
OBSERVATIONAL
Conditions
Summary
PHAGEinLYON Clinic cohort study is a single site non-interventional retrospective and prospective study, initiated by the Hospices Civils de Lyon. Population targeted are patients with a severe infection treated with bacteriophage in the Hospices civils de Lyon from 2015 to 2033. The primary objective is to describe the severe infections treated with phagotherapy. 250 patients will be included in the study.
Eligibility
Inclusion Criteria2
- Patient with severe infection treated with bacteriophage in the Hospices Civils de Lyon from 01/01/2015 to 01/01/2033
- PHAGEinLYON Clinic cohort study information notice provided to the patient
Exclusion Criteria1
- Opposition of trial participant
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Description of severe infections treated with bacteriophage in the Hospices Civils de Lyon from 2015 to 2033.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06185920